Measuring My Myeloma With MRD Testing: What Is My Disease State?

November 19, 2018



Download Guide (PDF)

An audience of myeloma patients and their care partners joined us online as myeloma experts explained the role of minimal residual disease (MRD) testing in myeloma.

We are also planning events in other cities. If you haven’t already, please sign up for email updates, so we can alert you when important and inspiring videos become available and when upcoming webinars and town meetings are scheduled.


Host & Guests
Host

Host, Patient Power Co-Founder, Two-Time Cancer Survivor and Patient Advocate


Guests

Assistant Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine



Myeloma Patient, Author and Blogger


This is a Patient Empowerment Network program produced by Patient Power in partnership with The University of Texas MD Anderson Cancer Center. We thank AbbVie, Inc., Celgene Corporation, and Sanofi for their support.

Patient Empowerment Network
The University of Texas MD Anderson Cancer Center
Patient Power
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on December 13, 2018